Hawley Secures Commitment from RFK’s Deputy Nominee to Review Chemical Abortion Data

For information about Senator Hawley’s new RECA law to compensate Missourians,click here.
Thursday, May 08, 2025
Today in a hearing in the Senate Committee on Health, Education, Labor and Pensions, U.S. Senator Josh Hawley (R-Mo.)secured a commitmentfrom Jim O’Neill – President Trump’s nominee to serve as Deputy Secretary of Health and Human Services – to conduct an updated safety review on the chemical abortion drug mifepristone if he were confirmed. The promise comes on the heels of anew studyshowing that1 in 10 womenwho take the drug suffer from adverse health effects.O’Neillagreedwith Senator Hawley that thenew studywarranted review, for the health and safety of women across the nation.“The Secretary [Robert F. Kennedy Jr.] has pledged to do a safety review of mifepristone, and I strongly support that view,”O’Neill said.Senator Hawley has been a staunch advocate for women across the nation, fromintroducing legislationto reinstate safeguards on mifepristone that the Biden Administration eliminated tourging the Department of Justiceto reconsider its position in Missouri’s mifepristone litigation.
###

"*" indicates required fields
381 Russell Senate Office BuildingWashington, D.C. 20510Office: 202-224-6154Fax: 202-228-0526
1123 Wilkes Blvd, Suite 220Columbia, MO 65201Office: 573-554-1919Fax: 573-256-1805
400 E. 9th Street, Suite 9350Kansas City, MO 64106Office: 816-960-4694Fax:816-472-6812
3236 E. Ridgeview StreetSpringfield, MO 65804Office: 417-869-4433
530 Maryville Centre DriveSuite 460St. Louis, MO 63141Office: 314-354-7060Fax: 1 314-436-8534
555 Independence Street, #1600Cape Girardeau, MO 63703Office: 573-334-5995Fax: 573-334-5947